Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cellebrite DI ( (CLBT) ) has provided an update.
On September 19, 2025, Cellebrite DI Ltd. held its annual general meeting where shareholders approved all proposals presented, with approximately 76.82% of the ordinary shares represented. This approval signifies strong shareholder support and could enhance the company’s strategic initiatives and governance, potentially impacting its market positioning positively.
The most recent analyst rating on (CLBT) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on Cellebrite DI stock, see the CLBT Stock Forecast page.
Spark’s Take on CLBT Stock
According to Spark, TipRanks’ AI Analyst, CLBT is a Neutral.
Cellebrite DI’s overall stock score is driven by strong technical momentum and strategic growth initiatives, despite challenges in profitability and valuation. The company’s low leverage and cash flow strength are positives, but improving profitability remains essential.
To see Spark’s full report on CLBT stock, click here.
More about Cellebrite DI
Cellebrite DI Ltd. operates in the digital intelligence industry, providing solutions for law enforcement, military, intelligence, and corporate customers to lawfully access, analyze, and manage digital data. The company focuses on digital forensics and investigative analytics, helping organizations accelerate investigations and achieve operational efficiency.
Average Trading Volume: 1,906,409
Technical Sentiment Signal: Strong Buy
Current Market Cap: $4.22B
See more insights into CLBT stock on TipRanks’ Stock Analysis page.